Sharda Cropchem Q3 Results 2025 on 25 Jan, 2025: profit rise by 571.34% YOY, profit at ₹31.15 crore and revenue at ₹929.33 crore | Company Business News
Sharda Cropchem Q3 Results 2025:Sharda Cropchem declared their Q3 results on 24 Jan, 2025, reporting a remarkable increase in both revenue and profit. The topline surged by 46.94% year-on-year, reaching ₹929.33 crore, while net profit soared by an astonishing 571.34% to ₹31.15 crore.
In comparison to the previous quarter, the revenue showed a growth of 19.62%, although profit experienced a decline of 26.55%. The rise in revenue and profit year-on-year highlights the company’s strong operational performance.
The company’s Selling, General & Administrative expenses rose by 18.42% quarter-on-quarter and increased by 31.2% year-on-year, reflecting the growing operational costs amid increased revenues.
The operating income also exhibited significant growth, up by 315.59% quarter-on-quarter and 477.68% year-on-year, indicating strong operational leverage.
Earnings Per Share (EPS) for Q3 stood at ₹3.45, marking an impressive increase of 576.47% year-on-year, further showcasing the company’s profitability improvement.
Sharda Cropchem has faced a challenging week with a return of -11.8%, however, it has shown a positive return of 16.35% over the last six months despite a year-to-date decline of -19.46%.
The current market capitalization of Sharda Cropchem stands at ₹5784.49 crore, with a 52-week high of ₹886.6 and a low of ₹318.05, indicating volatility in the stock performance.
As of 25 Jan, 2025, out of five analysts covering the company, two analysts have issued a Hold rating, two have rated it as Buy, and one analyst has given a Strong Buy rating.
The consensus recommendation as of 25 Jan, 2025, is to Buy, reflecting optimism among analysts regarding Sharda Cropchem’s future growth potential.
Sharda Cropchem Financials
| Period | Q3 (FY25) | Q2 (FY25) | Q-o-Q Growth | Q3 (FY24) | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 929.33 | 776.89 | +19.62% | 632.46 | +46.94% |
| Selling/ General/ Admin Expenses Total | 12.28 | 10.37 | +18.42% | 9.36 | +31.2% |
| Depreciation/ Amortization | 68.89 | 69.1 | -0.3% | 68.63 | +0.38% |
| Total Operating Expense | 844.05 | 756.37 | +11.59% | 655.05 | +28.85% |
| Operating Income | 85.28 | 20.52 | +315.59% | -22.58 | +477.68% |
| Net Income Before Taxes | 45.93 | 45.52 | +0.9% | 12.12 | +278.96% |
| Net Income | 31.15 | 42.41 | -26.55% | 4.64 | +571.34% |
| Diluted Normalized EPS | 3.45 | 4.7 | -26.6% | 0.51 | +576.47% |
Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.
